About
Technology
Issues
FAQ
Links
Official Page
Interim analysis of a randomized, open-label phase 2 study of talimogene laherparepvec (T-VEC) neoadjuvant treatment (neotx) plus surgery (surgx) vs surgx for resectable stage IIIB-IVM1a melanoma (MEL).
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.